Lataa...
Inhibition of mTOR by rapamycin does not improve hypoxic pulmonary hypertension-induced right heart failure in old mice
Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin attenuates heart failure (HF) and age-associated changes in left ventricular (LV) function. Rapamycin has also been suggested as a therapy for pulmonary hypertension (PH) and concomitant right heart failure (PH-RHF) based on reports...
Tallennettuna:
| Julkaisussa: | Exp Gerontol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8248895/ https://ncbi.nlm.nih.gov/pubmed/33971279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exger.2021.111395 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|